EMA starts evaluating an application for the use of a booster dose of Spikevax, Moderna’s #COVID19vaccine, to be given at least 6 months after the 2nd dose in people aged 12 years and older.
#VaccinesWork #publichealth
Read more:
👉 ema.europa.eu/en/news/ema-ev
